自主反应性IgE:自身免疫性疾病中的致病作用和治疗点
Nicolas Charles1,2, Inge Kortekaas-Krohn3,4, Emek Kocaturk5,6,7
1Faculté de Médecine site Bichat, Centre de Recherche sur l'Inflammation, INSERM UMR1149, CNRS EMR8252, Université Paris Cité, Paris, France.
Allergy
|August 9, 2023
概括
致病性自身反应性IgE抗体通过激活免疫细胞,有助于抗体介导的自身免疫性疾病. 需要进一步的研究来开发针对这些自身抗体的诊断工具和治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 这是一种自身免疫力.
- 过敏 过敏是一种过敏.
背景情况:
- 自身免疫包括自我耐受性的丧失,导致由自身反应性抗体 (AAb) 驱动的疾病.
- 虽然许多AAb是良性的,但有些是致病性的,导致抗体介导的自身免疫性疾病 (AbAID).
- 促炎症因素影响AAb的产生,同型和糖化.
研究的目的:
- 在ABAID中审查自身反应性IgE抗体的致病作用.
- 讨论自身反应性IgE作为潜在的治疗点.
- 为突出研究IgE自身抗体的当前挑战.
主要方法:
- 对 AbAID 中自身反应性IgE 的当前知识的文献综述.
- 讨论IgE介导的免疫反应.
- 对诊断和治疗影响的分析.
主要成果:
- 自主反应性IgE抗体可以通过FcεRI激活巨细胞和基细胞.
- IgE自身抗体可能会促进进一步的自身抗体产生和炎症.
- 有证据表明,IgE在各种ABAID中起着作用.
结论:
- 自主反应性IgE参与了ABAID的发病.
- IgE自身抗体是一个潜在的治疗点.
- 为了可靠量化,验证和理解IgE AAb病理生理学,需要进行进一步的研究.
相关概念视频
Autoimmune Disorders
494
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
494
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Gastritis-II: Pathophysiology
375
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
375
Allergic Drug Reactions
876
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
876
Inflammatory Response
2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173


